168 related articles for article (PubMed ID: 36997656)
1. Cardioprotective potential of mitochondria-targeted antioxidant, mito-TEMPO, in 5-fluorouracil-induced cardiotoxicity.
Tambe PK; Mathew AJ; Bharati S
Cancer Chemother Pharmacol; 2023 May; 91(5):389-400. PubMed ID: 36997656
[TBL] [Abstract][Full Text] [Related]
2. Mito-TEMPO mitigates 5-fluorouracil-induced intestinal injury via attenuating mitochondrial oxidative stress, inflammation, and apoptosis: an in vivo study.
Tambe PK; Qsee HS; Bharati S
Inflammopharmacology; 2023 Aug; 31(4):2091-2102. PubMed ID: 37338659
[TBL] [Abstract][Full Text] [Related]
3. Mitochondria-targeted antioxidant, mito-TEMPO mitigates initiation phase of N-Nitrosodiethylamine-induced hepatocarcinogenesis.
Shetty S; Anushree U; Kumar R; Bharati S
Mitochondrion; 2021 May; 58():123-130. PubMed ID: 33711502
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic inhibition of mitochondrial reactive oxygen species with mito-TEMPO reduces diabetic cardiomyopathy.
Ni R; Cao T; Xiong S; Ma J; Fan GC; Lacefield JC; Lu Y; Le Tissier S; Peng T
Free Radic Biol Med; 2016 Jan; 90():12-23. PubMed ID: 26577173
[TBL] [Abstract][Full Text] [Related]
5. Mito-TEMPO, a mitochondria-targeted antioxidant, prevents N-nitrosodiethylamine-induced hepatocarcinogenesis in mice.
Shetty S; Kumar R; Bharati S
Free Radic Biol Med; 2019 May; 136():76-86. PubMed ID: 30946961
[TBL] [Abstract][Full Text] [Related]
6. Mito-TEMPO protects against bisphenol-A-induced testicular toxicity: an in vivo study.
Shetty S; Kumar V; Ramesh V; Bharati S
Free Radic Res; 2022; 56(5-6):427-435. PubMed ID: 36205519
[TBL] [Abstract][Full Text] [Related]
7. Potential mechanisms of uremic muscle wasting and the protective role of the mitochondria-targeted antioxidant Mito-TEMPO.
Liu Y; Perumal E; Bi X; Wang Y; Ding W
Int Urol Nephrol; 2020 Aug; 52(8):1551-1561. PubMed ID: 32488756
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of renal mitochondrial respiratory complexes and manganese superoxide dismutase during sepsis: mitochondria-targeted antioxidant mitigates injury.
Patil NK; Parajuli N; MacMillan-Crow LA; Mayeux PR
Am J Physiol Renal Physiol; 2014 Apr; 306(7):F734-43. PubMed ID: 24500690
[TBL] [Abstract][Full Text] [Related]
9. Mitochondria-Targeted Antioxidant Mito-Tempo Protects Against Aldosterone-Induced Renal Injury In Vivo.
Ding W; Liu T; Bi X; Zhang Z
Cell Physiol Biochem; 2017; 44(2):741-750. PubMed ID: 29169180
[TBL] [Abstract][Full Text] [Related]
10. Mitochondria-targeted antioxidant Mito-Tempo protects against acetaminophen hepatotoxicity.
Du K; Farhood A; Jaeschke H
Arch Toxicol; 2017 Feb; 91(2):761-773. PubMed ID: 27002509
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment with Rho-kinase inhibitor ameliorates lethal endotoxemia-induced liver injury by improving mitochondrial function.
Ding R; Han J; Zhao D; Hu Z; Ma X
Int Immunopharmacol; 2016 Nov; 40():125-130. PubMed ID: 27588912
[TBL] [Abstract][Full Text] [Related]
12. Hepatoprotective Effect of Mitochondria-Targeted Antioxidant Mito-TEMPO against Lipopolysaccharide-Induced Liver Injury in Mouse.
Wang PF; Xie K; Cao YX; Zhang A
Mediators Inflamm; 2022; 2022():6394199. PubMed ID: 35769207
[TBL] [Abstract][Full Text] [Related]
13. Edaravone and benidipine protect myocardial damage by regulating mitochondrial stress, apoptosis signalling and cardiac biomarkers against doxorubicin-induced cardiotoxicity.
Hassan MQ; Akhtar MS; Afzal O; Hussain I; Akhtar M; Haque SE; Najmi AK
Clin Exp Hypertens; 2020 Jul; 42(5):381-392. PubMed ID: 31630586
[No Abstract] [Full Text] [Related]
14. Protective effect of thymoquinone nanoemulsion in reducing the cardiotoxic effect of 5-fluorouracil in rats.
Karim B; Arabameri M; Alimoradi F; Mansoori R; Moghadamnia AA; Kazemi S; Hosseini SM
Drug Dev Res; 2024 Apr; 85(2):e22171. PubMed ID: 38459752
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of mito-TEMPO against doxorubicin cardiotoxicity in mice.
Rocha VC; França LS; de Araújo CF; Ng AM; de Andrade CM; Andrade AC; Santos Ede S; Borges-Silva Mda C; Macambira SG; Noronha-Dutra AA; Pontes-de-Carvalho LC
Cancer Chemother Pharmacol; 2016 Mar; 77(3):659-62. PubMed ID: 26712129
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of combined administration of fluoxetine and mitochondria-targeted antioxidant at in behavioural and molecular studies in mice model of depression.
Herbet M; Szumełda I; Piątkowska-Chmiel I; Gawrońska-Grzywacz M; Dudka J
Behav Brain Res; 2021 May; 405():113185. PubMed ID: 33617903
[TBL] [Abstract][Full Text] [Related]
17. Mito-TEMPO Alleviates Renal Fibrosis by Reducing Inflammation, Mitochondrial Dysfunction, and Endoplasmic Reticulum Stress.
Liu Y; Wang Y; Ding W; Wang Y
Oxid Med Cell Longev; 2018; 2018():5828120. PubMed ID: 29765500
[TBL] [Abstract][Full Text] [Related]
18. Supplementation of Mito TEMPO and acetovanillone in semen extender improves freezability of buffalo spermatozoa.
Kumar A; Kumar Ghosh S; Katiyar R; Gemeda AE; Rautela R; Bisla A; Srivastava N; Kumar Bhure S; Devi HL; Chandra V
Andrology; 2022 May; 10(4):775-788. PubMed ID: 35060362
[TBL] [Abstract][Full Text] [Related]
19. Mito-Tempo alleviates cryodamage by regulating intracellular oxidative metabolism in spermatozoa from asthenozoospermic patients.
Zhang X; Lu X; Li J; Xia Q; Gao J; Wu B
Cryobiology; 2019 Dec; 91():18-22. PubMed ID: 31734127
[TBL] [Abstract][Full Text] [Related]
20. Critical role of mitochondrial oxidative stress in acid aspiration induced ALI in mice.
Puri G; Naura AS
Toxicol Mech Methods; 2020 May; 30(4):266-274. PubMed ID: 31900028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
